Skip Navigation LinksHome > July 2008 - Volume 27 - Issue 7 > Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotav...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e318168d29e
Brief Reports

Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine Based on Breastfeeding Frequency

Goveia, Michelle G. MD, MPH; DiNubile, Mark J. MD; Dallas, Michael J. PhD; Heaton, Penny M. MD; Kuter, Barbara J. PhD, MPH; for the REST Study Team

Collapse Box


The efficacy of a live, oral, pentavalent rotavirus vaccine against G1-4 rotavirus gastroenteritis (RVGE) was retrospectively assessed based on breastfeeding frequency among 5098 infants in a placebo-controlled trial. The efficacy against any RVGE severity for infants never breastfed, sometimes breastfed, or exclusively breastfed was 68.3%, 82.2%, and 68.0%, respectively. The efficacy against severe RVGE was 100%, 95.4%, and 100%, respectively. Breastfeeding did not seem to adversely impact the efficacy of pentavalent rotavirus vaccine.

© 2008 Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.